GlassScriptPhysician profile
Deanna N Johnson
NPI 1316447881
$734.13
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $162 · 2023: $33.86 · 2024: $159 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $200.70 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $147.51 | 2021-2025 | Jynarque |
| Fresenius USA Marketing, INC. | $132.27 | 2021-2023 | Korsuva, Velphoro |
| Novo Nordisk INC | $45.59 | 2023-2025 | Ozempic |
| Horizon Therapeutics Plc | $40.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.23 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.41 | 2025 | Givlaari |
| Alexion Pharmaceuticals, INC. | $23.60 | 2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $19.17 | 2022 | |
| Glaxosmithkline, LLC. | $18.33 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $17.29 | 2025 | |
| Mallinckrodt Hospital Products INC. | $16.14 | 2022 | |
| Corcept Therapeutics | $14.90 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.